Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀº ¿¬Æò±Õ 33.47% ¼ºÀåÇÏ¿© 2024³â 17¾ï 1,600¸¸ ´Þ·¯ ±Ô¸ð¿¡¼ 2029³â 72¾ï 6,800¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀΰøÁö´É(AI) Áø´Ü Ȱ¿ëÀº ÀÇ·á Áø´Ü°ú Ä¡·á¿¡ º¯È¸¦ °¡Á®¿ÔÀ¸¸ç, AI ¾Ë°í¸®Áò°ú ¸Ó½Å·¯´× Á¢±Ù¹ýÀº ¹æ´ëÇÑ ¾çÀÇ ÀÇ·á µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© Á¤È®Çϰí È¿À²ÀûÀÎ Áø´ÜÀ» À§ÇÑ Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â µ¥ ÀÖ¾î ³î¶ó¿î ´É·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÀΰøÁö´É ±â¹Ý Áø´ÜÀº ¹æ»ç¼±°ú º´¸®Çп¡¼ ½ÉÀ庴ÇÐ, ¾Ï Áø´Ü¿¡ À̸£±â±îÁö ÀÇ·á ºÐ¾ß¿¡¼ Å« ¹ßÀüÀ» °¡Á®¿ÔÀ¸¸ç, AI ±â¹Ý ±â¼úÀº ÀÇ·áÁøÀÇ ±â¼úÀ» Çâ»ó½ÃÄÑ Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í ±ÍÁßÇÑ ½Ã°£À» Àý¾àÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÀÌ·¯ÇÑ AI ½Ã½ºÅÛÀº ½ÇÁ¦ µ¥ÀÌÅ͸¦ ÅëÇØ ÇнÀÇÏ°í ½Ã°£ÀÌ Áö³²¿¡ µû¶ó °³¼±ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÇ·áÁø¿¡°Ô ¸Å¿ì ÁÁÀº ÆÄÆ®³Ê°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ ¼ºÀåÀº ´õ ºü¸£°í Á¤È®ÇÑ Áø´ÜÀ» Á¦°øÇϰí, ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí, »ý¸íÀ» ±¸ÇÔÀ¸·Î½á ÀÇ·á ¼ºñ½º Á¦°ø¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
¸Ó½Å·¯´×°ú µö·¯´× ¾Ë°í¸®ÁòÀÇ ¹ßÀüÀ¸·Î Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ ¼ºÀåÀÌ °ÈµÆ½À´Ï´Ù.
¸Ó½Å·¯´×°ú µö·¯´× ¾Ë°í¸®ÁòÀº Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡ µû¸£¸é, µö·¯´× ½Ã½ºÅÛÀº ÇǺξÏÀ» 94.5%ÀÇ Á¤È®µµ·Î °ËÃâÇØ Àΰ£ ÇǺΰú Àǻ縦 ´É°¡ÇÏ´Â Á¤È®µµ¸¦ º¸¿´À¸¸ç, ¹Ì±¹ ÀÇÇÐÇùȸ Àú³Î(Journal of the American Medical Association)¿¡ °ÔÀçµÈ ¿¬±¸ °á°ú¿¡ µû¸£¸é, AI ½Ã½ºÅÛÀº À¯¹æ¾ÏÀ» Áø´ÜÇÒ ¶§ Àΰ£ ÇǺΰú Àǻ縦 ´É°¡ÇÏ´Â Á¤È®µµ¸¦ º¸¿´½À´Ï´Ù. ¶ÇÇÑ Journal of the American Medical Association¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, AI ½Ã½ºÅÛÀº 94.5%ÀÇ ¹Î°¨µµ·Î À¯¹æÃÔ¿µ¼ú¿¡¼ À¯¹æ¾ÏÀ» Á¤È®ÇÏ°Ô ÀνÄÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº Áø´Ü Á¤È®µµ¿Í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â ¸Ó½Å·¯´× ¹× µö·¯´× ¾Ë°í¸®ÁòÀÇ ÈûÀ» ÀÔÁõÇϰí ÀÖ½À´Ï´Ù.
Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ Áö¸®Àû Àü¸Á
- ºÏ¹Ì´Â Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ ¼±µÎÁÖÀÚÀÔ´Ï´Ù.
ºÏ¹Ì´Â Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â °·ÂÇÑ ÀÇ·á ÀÎÇÁ¶ó, ½Å±â¼ú, ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æ µîÀÇ ¿äÀΰú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â Àú¸íÇÑ ÀÇ·á ½Ã¼³°ú ¿¬±¸ ±â°ü µî AI ºñÁî´Ï½º¿¡¼ Áß¿äÇÑ ±â¾÷µéÀÌ ´Ù¼ö Á¸ÀçÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì¿¡¼´Â AI ¿¬±¸°³¹ß¿¡ ´ëÇÑ ´ë±Ô¸ð ÁöÃâÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌ´Â Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ±â¼ú Çõ½Å°ú ±â¼ú °³¹ß¿¡ ÁßÁ¡À» µÎ°í Àֱ⠶§¹®¿¡ Áø´Ü ¸ñÀûÀ¸·Î AI¸¦ Áö¼ÓÀûÀ¸·Î äÅÃÇϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¸¦ ±¸¸ÅÇØ¾ß ÇÏ´Â ÀÌÀ¯
- ÅëÂû·Â ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷ ºÐ¾ß ¹× ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃß¾î ÁÖ¿ä Áö¿ª°ú ½ÅÈï Áö¿ªÀ» Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
- °æÀï ȯ°æ: ¼¼°è ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ÀûÀýÇÑ Àü·«À» ÅëÇÑ ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÕ´Ï´Ù.
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ÇâÈÄ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í À̵éÀÌ ÇâÈÄ ½ÃÀå ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀÎÁö¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.
- ½ÇÇà °¡´ÉÇÑ Á¦¾È: ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» âÃâÇϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÅëÂû·ÂÀ» Ȱ¿ëÇÕ´Ï´Ù.
- ±¤¹üÀ§ÇÑ µ¶ÀÚÃþ: ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÓ.
±â¾÷Àº ¾î¶² ¸ñÀûÀ¸·Î ¿ì¸®ÀÇ º¸°í¼¸¦ »ç¿ëÇϳª¿ä?
»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ
Á¶»ç ¹üÀ§
- 2022³âºÎÅÍ 2029³â±îÁöÀÇ °ú°Å µ¥ÀÌÅÍ ¹× Àü¸Á
- ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °í°´ Çൿ, Æ®·»µå ºÐ¼®
- °æÀï»ç ½ÃÀå »óȲ, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
- °¢ ±¹°¡¸¦ Æ÷ÇÔÇÑ ºÎ¹® ¹× Áö¿ªº° ¼öÀÍ ¼ºÀå ¹× ¿¹Ãø Æò°¡
- ±â¾÷ ÇÁ·ÎÆÄÀÏ(Àü·«, Á¦Ç°, À繫 Á¤º¸, ÁÖ¿ä ¹ßÀü µî)
Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀº ´ÙÀ½°ú °°ÀÌ ¼¼ºÐÈÇÏ¿© ºÐ¼®Çß½À´Ï´Ù.
±¸¼º ¿ä¼Òº°
Áø´Ü À¯Çüº°
- ¹æ»ç¼±°ú
- º´¸®ÇÐ
- ½ÉÀåÇÐ
- Á¾¾çÇÐ
- ½Å°æÇÐ
- ±âŸ
¿ëµµº°
- Áúº´ °¨Áö
- À̹ÌÁö ºÐ¼®
- À§Çè Æò°¡
- ¿¹Ãø ºÐ¼®
- ±âŸ
ÃÖÁ¾»ç¿ëÀÚº°
- º´¿ø ¹× Áø·á¼Ò
- Áø´Ü ½ÇÇè½Ç
- ¿¬±¸±â°ü
- ±âŸ
Áö¿ªº°
- ºÏ¹Ì
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- ³²¹Ì
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- ´ë¸¸
- ±âŸ
¸ñÂ÷
Á¦1Àå ¼·Ð
- ½ÃÀå °³¿ä
- ½ÃÀåÀÇ Á¤ÀÇ
- Á¶»ç ¹üÀ§
- ½ÃÀå ¼¼ºÐÈ
- ÅëÈ
- ÀüÁ¦Á¶°Ç
- ±âÁسâ°ú ¿¹Ãø³â ŸÀÓ¶óÀÎ
Á¦2Àå Á¶»ç ¹æ¹ý
- Á¶»ç µ¥ÀÌÅÍ
- ̉˟
- Á¶»ç µðÀÚÀÎ
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- PorterÀÇ Five Forces ºÐ¼®
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ¹ÙÀ̾îÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- ¾÷°è³» °æÀï ±â¾÷°£ °æÀï °ü°è
- ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ÄÄÆ÷³ÍÆ®º°
Á¦6Àå Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : Áø´Ü À¯Çüº°
- ¼·Ð
- ¹æ»ç¼±°ú
- º´¸®ÇÐ
- ½ÉÀ庴ÇÐ
- Á¾¾çÇÐ
- ½Å°æÇÐ
- ±âŸ
Á¦7Àå Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ¿ëµµº°
- ¼·Ð
- Áúȯ ŽÁö
- ¿µ»ó ºÐ¼®
- ¸®½ºÅ© Æò°¡
- ¿¹Ãø ºÐ¼®
- ±âŸ
Á¦8Àå Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ¼·Ð
- º´¿ø ¹× Áø·á¼Ò
- Áø´Ü ½ÇÇè½Ç
- ¿¬±¸±â°ü
- ±âŸ
Á¦9Àå Áø´Ü ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : Áö¿ªº°
- ¼·Ð
- ºÏ¹Ì
- ³²¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âŸ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- ´ë¸¸
- ±âŸ
Á¦10Àå °æÀï ȯ°æ°ú ºÐ¼®
- ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
- ½Å±Ô ±â¾÷°ú ½ÃÀå ¼öÀͼº
- ÇÕº´, Àμö, ÇÕÀÇ ¹× Çù¾÷
- º¥´õ °æÀï·Â ¸ÅÆ®¸¯½º
Á¦11Àå ±â¾÷ °³¿ä
- IBM CORPORATION
- GENERAL ELECTRIC(GE) COMPANY
- SIEMENS HEALTHINEERS AG
- AIDOC MEDICAL LTD.
- ZEBRA MEDICAL VISION LTD.
- BUTTERFLY NETWORK, INC.
- VIZ.AI, INC.
- IMAGEN TECHNOLOGIES, INC.
- ALIVECOR, INC.
- PATHAI, INC.
LSH
The AI in diagnostics market is expected to grow at a CAGR of 33.47%, reaching a market size of US$7.268 billion in 2029 from US$1.716 billion in 2024.
The use of Artificial Intelligence (AI) in the diagnostics market has transformed medical diagnosis and therapy. AI algorithms and machine learning approaches have shown impressive skills in analyzing massive volumes of medical data and producing significant insights for accurate and efficient diagnosis. Artificial intelligence-driven diagnosis is promoting significant development in the medical sector, from radiology and pathology to cardiology and cancer diagnosis. With the enhanced skills of practitioners using AI-enabled technologies, diagnostic accuracies increase, saving valuable time.
In addition, these AI systems can learn from real-world data and improve over time, therefore proving to be very good companions for healthcare practitioners. The AI in diagnostics market growth has enormous promise for revolutionizing healthcare delivery by offering faster, more accurate diagnoses, improving patient outcomes, and saving lives.
Advancements in Machine Learning and Deep Learning Algorithms enhanced the AI in Diagnostics Market Growth.
Machine learning and deep learning algorithms have significantly contributed to the expansion of AI in the diagnostics business. These algorithms have shown an extraordinary ability to handle and analyze massive volumes of medical data, allowing for precise and rapid diagnosis. According to a report published by WHO, a deep learning system detected skin cancer with an accuracy of 94.5%, outperforming human dermatologists. Furthermore, according to a study published in the Journal of the American Medical Association, an AI system properly recognized breast cancer in mammograms with a sensitivity of 94.5%. These developments demonstrate the power of machine learning and deep learning algorithms in improving diagnostic accuracy and patient outcomes.
AI in the Diagnostics Market Geographical Outlook
- North America is the Market Leader in the AI Diagnostics Market.
North America holds a significant share of the AI Diagnostics market. This can be linked to factors such as a strong healthcare infrastructure, new technologies, and a favorable regulatory environment. Several significant players in the AI business, including prominent healthcare facilities and research organizations, are located in the region. Furthermore, North America has seen major expenditures in AI research and development, which has fueled the expansion of AI in the diagnostics market. North America continues to employ AI for diagnostic purposes, thanks to an emphasis on innovation and technical developments.
Reasons for buying this report:-
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
- Historical data & forecasts from 2022 to 2029
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
AI in the Diagnostics market is segmented and analyzed as given below:
By Component
By Diagnostic Type
- Radiology
- Pathology
- Cardiology
- Oncology
- Neurology
- Others
By Application
- Disease Detection
- Image Analysis
- Risk Assessment
- Predictive Analysis
- Others
By End-User
- Hospitals And Clinics
- Diagnostic Laboratories
- Research Institutions
- Others
By Geography
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Indonesia
- Taiwan
- Others
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. MARKET OVERVIEW
- 1.2. Market Definition
- 1.3. Scope of the Study
- 1.4. Market Segmentation
- 1.5. Currency
- 1.6. Assumptions
- 1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
- 2.1. Research Data
- 2.2. Sources
- 2.3. Research Design
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1. Market Drivers
- 4.2. Market Restraints
- 4.3. Porters Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
- 4.4. Industry Value Chain Analysis
5. AI IN DIAGNOSTICS MARKET, BY COMPONENT
- 5.1. Introduction
- 5.2. SOFTWARE
- 5.3. HARDWARE
6. AI IN DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE
- 6.1. Introduction
- 6.2. Radiology
- 6.3. Pathology
- 6.4. Cardiology
- 6.5. Oncology
- 6.6. Neurology
- 6.7. Others
7. AI IN DIAGNOSTICS MARKET, BY APPLICATION
- 7.1. Introduction
- 7.2. Disease Detection
- 7.3. Image Analysis
- 7.4. Risk Assessment
- 7.5. Predictive Analysis
- 7.6. Others
8. AI IN DIAGNOSTICS MARKET, BY END-USER
- 8.1. Introduction
- 8.2. Hospitals and Clinics
- 8.3. Diagnostic Laboratories
- 8.4. Research Institutions
- 8.5. Others
9. AI IN DIAGNOSTICS MARKET, BY GEOGRAPHY
- 9.1. Introduction
- 9.2. North America
- 9.2.1. United States
- 9.2.2. Canada
- 9.2.3. Mexico
- 9.3. South America
- 9.3.1. Brazil
- 9.3.2. Argentina
- 9.3.3. Others
- 9.4. Europe
- 9.4.1. United Kingdom
- 9.4.2. Germany
- 9.4.3. France
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Others
- 9.5. Middle East and Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. Others
- 9.6. Asia Pacific
- 9.6.1. Japan
- 9.6.2. China
- 9.6.3. India
- 9.6.4. South Korea
- 9.6.5. Indonesia
- 9.6.6. Taiwan
- 9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 10.1. Major Players and Strategy Analysis
- 10.2. Emerging Players and Market Lucrativeness
- 10.3. Mergers, Acquisitions, Agreements, and Collaborations
- 10.4. Vendor Competitiveness Matrix
11. COMPANY PROFILES
- 11.1. IBM CORPORATION
- 11.2. GENERAL ELECTRIC (GE) COMPANY
- 11.3. SIEMENS HEALTHINEERS AG
- 11.4. AIDOC MEDICAL LTD.
- 11.5. ZEBRA MEDICAL VISION LTD.
- 11.6. BUTTERFLY NETWORK, INC.
- 11.7. VIZ.AI, INC.
- 11.8. IMAGEN TECHNOLOGIES, INC.
- 11.9. ALIVECOR, INC.
- 11.10. PATHAI, INC.